Novel use for PDE5 inhibitors

Details for Australian Patent Application No. 2005224043 (hide)

Owner Nycomed GmbH

Inventors Rosengarten, Bernhard; Kaps, Manfred; Grimminger, Friedrich; Schudt, Christian; Ghofrani, Hossein Ardeschir; Dunkern, Torsten

Agent Griffith Hack

Pub. Number AU-B-2005224043

PCT Pub. Number WO2005/089766

Priority 04100909.3 05.03.04 EP

Filing date 3 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 24 June 2010

International Classifications

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/089766 Priority application(s): WO2005/089766

9 November 2006 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Ghofrani, Ardeschir to Ghofrani, Hossein Ardeschir

22 November 2007 Change of Name(s) of Applicant(s), Section 104

  ALTANA Pharma AG The name of the applicant has been changed to Nycomed GmbH

24 June 2010 Application Accepted

  Published as AU-B-2005224043

21 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224048-Benzisoxazoles

2005224041-(Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor